Literature DB >> 29125329

Digital breast tomosynthesis findings may be different in HER2 positive breast cancer patients according to hormone receptor status.

Kadri Altundag1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 29125329      PMCID： PMC5965795          DOI： 10.1259/bjr.20170730

Source DB:  PubMed          Journal:  Br J Radiol        ISSN： 0007-1285            Impact factor:   3.039


× No keyword cloud information.
  2 in total

1.  Imaging features of breast cancers on digital breast tomosynthesis according to molecular subtype: association with breast cancer detection.

Authors:  Su Hyun Lee; Jung Min Chang; Sung Ui Shin; A Jung Chu; Ann Yi; Nariya Cho; Woo Kyung Moon
Journal:  Br J Radiol       Date:  2017-10-09       Impact factor: 3.039

2.  Association Between Imaging Characteristics and Different Molecular Subtypes of Breast Cancer.

Authors:  Mingxiang Wu; Jie Ma
Journal:  Acad Radiol       Date:  2016-12-09       Impact factor: 3.173
  2 in total
  1 in total

1.  Pre-Clinical Study of the [18F]AlF-Labeled HER2 Affibody for Non-Invasive HER2 Detection in Gastric Cancer.

Authors:  Jingya Han; Yang Chen; Yan Zhao; Xinming Zhao; Jingmian Zhang; Jianfang Wang; Zhaoqi Zhang
Journal:  Front Med (Lausanne)       Date:  2022-02-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.